Pelvic organ prolapse
Conditions
Interventions
POP group:N/A
Control group:N/A
Sponsors
Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Eligibility
Sex/Gender
Female
Age
40 Years to 90 Years
Inclusion criteria
Inclusion criteria: People who have undergone total hysterectomy (with POP or other benign gynaecological conditions other than exclusion criteria)
Exclusion criteria
Exclusion criteria: (1) History of malignant tumors; (2) autoimmune and connective tissue diseases; (3) after hysterectomy; (4) After pelvic floor repair; (5) Endometriosis, adenomyosis; (6) Non-ovarian endocrine tumors and other estrogen-related diseases; (7) acute and chronic pelvic inflammatory disease and pelvic inflammatory disease sequelae; (8) Known human immunodeficiency virus (HIV) infection; (9) Other investigators believe that it is not suitable for this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of genes related to collagen expression; | — |
Countries
CHINA
Contacts
Public ContactYonghong Lin
Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Outcome results
None listed